Home › Funds › Redmile Group, LLC › ATRA
Redmile Group, LLC position in ATRA
ATARA BIOTHERAPEUTICS INC · Health Care
Redmile Group, LLC reported holding 441,701 shares of ATRA (ATARA BIOTHERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$5.1M, representing 0.34% of its reported portfolio and ranking #34 among its reported holdings. Redmile Group, LLC has disclosed ATRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Redmile Group, LLC's ATRA position evolved
Redmile Group, LLC first disclosed a stake in ATRA in Q3 2023 at 6,280,813 shares (US$9.3M). Across 12 filings, Redmile Group, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 441,701 shares valued at US$5.1M. Notable position changes include a 45% increase in Q4 2023 (shares rose 35% over the following quarter), a 95% trim in Q2 2024 (shares fell 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 6.28M | $9.30M | New |
| Q4 2023 | 9.11M | $4.67M | Add |
| Q1 2024 | 9.26M | $6.43M | Add |
| Q2 2024 | 452.27K | $3.84M | Reduce |
| Q3 2024 | 452.27K | $3.68M | Hold |
| Q4 2024 | 441.70K | $5.88M | Reduce |
| Q1 2025 | 441.70K | $2.62M | Hold |
| Q2 2025 | 441.70K | $3.41M | Hold |
| Q3 2025 | 441.70K | $6.33M | Hold |
| Q4 2025 | 441.70K | $7.99M | Hold |
| Q1 2026 | 441.70K | $2.09M | Hold |
| Q2 2026 | 441.70K | $5.07M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ATRA and 13F data
ATRA (ATARA BIOTHERAPEUTICS INC) is a Health Care company. 12 other funds we track also report a position in ATRA — the largest reported positions include EcoR1 Capital, LLC (US$17.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on Redmile Group, LLC
FAQ
How long has Redmile Group, LLC held ATRA?
Redmile Group, LLC has disclosed ATRA holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Redmile Group, LLC's current position in ATRA?
As of Q2 2026, Redmile Group, LLC holds 441.70K shares of ATRA (ATARA BIOTHERAPEUTICS INC), valued at $5.07M, representing 0.34% of its reported portfolio and ranking #34.
Has Redmile Group, LLC been buying or selling ATRA?
In the latest 13F filing (Q2 2026), Redmile Group, LLC held unchanged its position in ATRA.
Which other funds hold ATRA?
Other major institutional holders of ATRA include EcoR1 Capital, LLC, among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.